TAVOCEPT Trademark

Trademark Overview

On Thursday, July 11, 2019, a trademark application was filed for TAVOCEPT with the United States Patent and Trademark Office. The USPTO has given the TAVOCEPT trademark a serial number of 88510012. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 7, 2022. This trademark is owned by Lantern Pharma Inc.. The TAVOCEPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatment of cancer; pharmaceutical preparations for the treatment of cancer
tavocept

General Information

Serial Number88510012
Word MarkTAVOCEPT
Filing DateThursday, July 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatment of cancer; pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLantern Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75201
Party NameLantern Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Trademark Events

Event DateEvent Description
Monday, February 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 27, 2021EXTENSION 3 GRANTED
Sunday, June 27, 2021EXTENSION 3 FILED
Sunday, June 27, 2021TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021EXTENSION 2 GRANTED
Thursday, December 31, 2020EXTENSION 2 FILED
Wednesday, January 13, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, January 12, 2021EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, January 12, 2021PETITION TO REVIVE-GRANTED
Tuesday, January 12, 2021TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2020EXTENSION 1 GRANTED
Tuesday, June 30, 2020EXTENSION 1 FILED
Thursday, September 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 30, 2020NOTICE OF REVIVAL - E-MAILED
Wednesday, July 29, 2020EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 29, 2020PETITION TO REVIVE-GRANTED
Wednesday, July 29, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 31, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 26, 2019ASSIGNED TO EXAMINER
Wednesday, July 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 15, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

tavocept pharmaceutical treatment cancer preparations regimens used namely medications chemotherapeutic